Product
Gallium-68 DOTATATE
1 clinical trial
1 indication
Indication
Breast Cancer Stage IVClinical trial
Somatostatin Receptor Imaging Study of Estrogen Receptor Positive (ER+) Metastatic Breast CancerStatus: Active (not recruiting), Estimated PCD: 2024-07-31